Catalog name Description price
R-Mcs-600 DiI-blank liposomes DiI-blank liposomes/DiI labeled blank liposomes are drug free fluorescent liposomes that stably embed lipophilic DiI fluorescent dyes into phospholipid bilayers. They are the most fundamental standardized fluorescent tool materials in the fields of liposome tracking, cell uptake, and in vivo biological distribution research. price>
R-Mcs-601 DiR Liposome surface peptide targets peg2k-PECAM-1(CD31) DiR Liposome surface peptide targets peg2k-PECAM-1 (CD31) is a highly penetrative active targeting fluorescent liposome with near-infrared two zone edge, specifically used for high specificity in vivo imaging and targeted drug delivery research of deep vascular tissue. Compared with similar probes labeled with visible light fluorescence, the tissue penetration ability is improved several times. price>
R-Mcs-602 DiR Liposome@Pemafibrate(K-877) DiR Liposome@Pemafibrate(K-877)/DiR Liposome loaded drug Pemafibrate (K-877) is an integrated near-infrared fluorescent drug carrier liposome with near-infrared fluorescent dye DiR embedded in phospholipid membrane and highly efficient encapsulation of a new generation of selective PPAR α regulator Permafibrate (K-877). It is a characteristic visual targeting drug delivery system in the research field of hyperlipidemia and atherosclerosis. price>
R-Mcs-603 DiR-blank liposomes DiR blank liposomes/DiR labeled blank liposomes are drug free blank near-infrared fluorescent liposomes stably embedded in phospholipid bilayers with near-infrared lipophilic fluorescent dye DiR. They are the basic standardized near-infrared tool materials in the fields of deep in vivo imaging and in vivo biological distribution research of liposomes. Compared with blank liposomes labeled with visible light fluorescence, the tissue penetration ability is significantly improved. price>
R-Mcs-604 ICG and Lenvatinib loaded liposomes ICG and Lenvatinib loaded liposomes are multifunctional liposomes encapsulated with indocyanine green (ICG) and the first-line targeted drug lenvatinib for liver cancer. They are a cutting-edge customized nano delivery system in the field of photothermal targeted synergistic therapy for hepatocellular carcinoma, capable of achieving precise combination therapy guided by near-infrared fluorescence imaging. price>
R-M1-8762 LNP-cy5/RGD,100nm Liposome nanoparticles-cy5/RGD can be utilized in various applications, such as cancer imaging, targeted drug delivery, or theranostics (simultaneous diagnosis and therapy). price>
R-M1-8763 FITC-Ti3C2,200nm-1000nm FITC-Ti3C2/Fluorescein Isothiocyanate-Ti3C2 has the potential to be used for applications such as fluorescent labeling, bioimaging, drug delivery, or biosensing, where the fluorescence of FITC can be employed for visualization purposes, while the TI3C2 nanoparticles contribute their desirable properties for specific functionalities or carrier capabilities. price>
R-M1-cs8773 CY7@EScu@ROSlnp-YSAYPDSVPMMS ROS responsive liposome nanoparticles encapsulate ESCU and CY7 surface modified peptides,CY7@EScu@ROSlnp-YSAYPDSVPMMS from ruixi.This system combines the benefits of ROS-responsive liposome nanoparticles with the specific properties of ESCU and CY7 surface-modified peptides, potentially enabling targeted drug delivery or imaging in ROS-rich environments. price>
R-M1-cs8774 Cyanine7@ES@ROSlnp-YSAYPDSVPMMS ROS responsive liposome nanoparticles encapsulate ES and CY7 surface modified peptides.By encapsulating ES and CY7 surface-modified peptides within the ROS-responsive liposome nanoparticles, it is possible to achieve targeted delivery or imaging in ROS-rich environments. The surface modifications on the peptides can facilitate specific interactions with the target cells or tissues, while the ROS-responsive nature of the liposomes regulates the release of the peptides in response to the local ROS levels. price>
R-M1-cs8799 ROS responsive liposomes loaded with CE6 ROS responsive liposomes loaded with CE6 (chlorin e6) are a type of drug delivery system designed to specifically target and respond to reactive oxygen species (ROS) in the body. Upon destabilization, the liposomes release the CE6 into the surrounding tissues. The released CE6 can then undergo a photochemical reaction when activated by specific wavelengths of light, generating highly reactive singlet oxygen species. This localized generation of singlet oxygen can induce cell death, making it particularly suitable for photodynamic therapy (PDT) applications. By specifically targeting and releasing the CE6 in ROS-rich areas, ROS responsive liposomes loaded with CE6 can enhance the therapeutic efficacy of photodynamic therapy while minimizing off-target effects. price>